TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05822882

Intervention type: PROCEDURE
Intervention: Epidural anesthesia
Description: Postoperative pain management by epidural anesthesia via epidural catheter and pain pump
Study: NCT05852067

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: pcTBS of M1
Description: Prolonged continuous theta-burst stimulation (pcTBS) was administered to the left M1 at 80% RMT, consisting of a burst of 3 pulses given at 50 Hz repeated every 5 Hz. A total of 1,200 pulses were delivered with the TMS coil positioned in a posterior-anterior (PA) direction parallel to the midline

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: SHAM stimulation
Description: The Sham stimulation was delivered using the same pcTBS protocol, with the coil being flipped 90◦to the scalp so that the magnetic field would be delivered away from the scalp
Study: NCT03976908

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation
Description: High frequency deep brain stimulation in the medial geniculate body of the thalamus.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation
Description: High frequency deep brain stimulation in the medial geniculate body of the thalamus.
Study: NCT06103045

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: unilateral and bilateral mirror therapy
Description: The mirror box is placed on a table in the sagittal plane of the participant. The affected upper extremity of the participant is hidden in the morror box and the unaffected upper extremity is placed symmetrically. During the unilateral or bilateral mirror therapy, the participant is requested to execute a serial of movements and tasks and pay attention on observing the reflection of the unaffected side in the mirror simultaneously. In the bilateral mirror therapy, the participant also has to move the affected upper extremity simultaneously; while in the unilateral mirror therapy, the participant only keeps the affected side relaxed.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: unilateral and bilateral mirror therapy
Description: The mirror box is placed on a table in the sagittal plane of the participant. The affected upper extremity of the participant is hidden in the morror box and the unaffected upper extremity is placed symmetrically. During the unilateral or bilateral mirror therapy, the participant is requested to execute a serial of movements and tasks and pay attention on observing the reflection of the unaffected side in the mirror simultaneously. In the bilateral mirror therapy, the participant also has to move the affected upper extremity simultaneously; while in the unilateral mirror therapy, the participant only keeps the affected side relaxed.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: unilateral and bilateral mirror therapy
Description: The mirror box is placed on a table in the sagittal plane of the participant. The affected upper extremity of the participant is hidden in the morror box and the unaffected upper extremity is placed symmetrically. During the unilateral or bilateral mirror therapy, the participant is requested to execute a serial of movements and tasks and pay attention on observing the reflection of the unaffected side in the mirror simultaneously. In the bilateral mirror therapy, the participant also has to move the affected upper extremity simultaneously; while in the unilateral mirror therapy, the participant only keeps the affected side relaxed.
Study: NCT05042700

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melatonin
Description: Enema with 25 mg melatonin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melatonin
Description: Enema with 25 mg melatonin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Enema without melatonin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Enema without melatonin
Study: NCT06136780

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Free reading glasses immediately following surgery
Description: Free reading glasses will be given immediately after cataract surgery in the intervention arm and four months after cataract surgery in the control arm.
Study: NCT06081543

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketogenic diet
Description: Participants will undertake a controlled feeding intervention. All food will be prepared and delivered to participants by research staff for the first 6 weeks. After that will be a free-living diet period where food will not be supplied but participants will receive educational materials and frequent coaching from a dietitian to help maintain the specified diet. Participants will be asked to exclusively follow the diet in efforts to control any dietary effects.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Low-fat Mixed diet
Description: Participants will undertake a controlled feeding intervention. All food will be prepared and delivered to participants by research staff for the first 6 weeks. After that will be a free-living diet period where food will not be supplied but participants will receive educational materials and frequent coaching from a dietitian to help maintain the specified diet. Participants will be asked to exclusively follow the diet in efforts to control any dietary effects.
Study: NCT06142539

Intervention type: RADIATION
Intervention: CT Radiation Doses
Description: Obtaining Low CT Radiation Doses by Adjusting Dose Levels
Study: NCT05229185

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DeXtreme training (error-enhancement)
Description: 15-20 min DeXtreme - 15 min conventional therapy - 15-20 min DeXtreme
Study: NCT06076148

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality games
Description: three individual games (physical, cognitive and relaxation) and two multiplayer games will be tested.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality games
Description: three individual games (physical, cognitive and relaxation) and two multiplayer games will be tested.
Study: NCT06202495

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser and Fluoride
Description: topic application of amino-fluoride gel (Elmex Dental Gel, Colgate-Palmolive company, New York, 300 Park Ave, United States) in association 980nm diode laser (doctor smile wiser by Lambda s.p.a. Via dell'Impresa, 1, 36040 Brendola VI, Italy) 1.5 W, pulsed mode 2 mm from tooth surface

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fluoride
Description: topic application of amino-fluoride gel (Elmex Dental Gel, Colgate-Palmolive company, New York, 300 Park Ave, United States)
Study: NCT06136364

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CAR-T
Description: CAR-T immunotherapy targeting CD7+
Study: NCT06109363

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for insomnia (CBT-I)
Description: CBT-I intervention will be provided to participants once their districts are exposed.
Study: NCT04874935

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lansoprazole
Description: administration of lansoprazole 60 mg twice daily 4 days before starting neoadjuvant chemotherapy regimen and continue till end of chemotherapy cycles

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: administration of Placebo capsule twice daily 4 days before starting neoadjuvant chemotherapy regimen and continue till end of chemotherapy cycles
Study: NCT06002204

Intervention type: OTHER
Intervention: Observational Study
Description: No Treatment or Intervention Provided

Intervention type: OTHER
Intervention: Observational Study
Description: No Treatment or Intervention Provided

Intervention type: OTHER
Intervention: Observational Study
Description: No Treatment or Intervention Provided
Study: NCT05092087

Intervention type: BEHAVIORAL
Intervention: nutrition counseling
Description: nutrition counseling

Intervention type: BEHAVIORAL
Intervention: nutrition counseling
Description: nutrition counseling
Study: NCT04275037

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Isometric Handgrip Training
Description: The 8-week exercise program will include three sessions of isometric handgrip training per week

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic Exercise Training
Description: The 8-week exercise program will include three sessions of aerobic exercise per week
Study: NCT05811481

Intervention type: PROCEDURE
Intervention: TACE
Description: Transcatheter Arterial Chemoembolization

Intervention type: DRUG
Intervention: Regorafenib
Description: Regorafenib alone

Intervention type: DRUG
Intervention: Regorafenib
Description: Regorafenib alone
Study: NCT04708730

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Delipid Extracorporeal Lipoprotein filter from Plasma
Description: As a non-pharmacological therapy, Delipid Extracorporeal Lipoprotein filter from Plasma (DELP) hase been approved by China Food and Drug Administration to treat acute stroke
Study: NCT06277310

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3 Wishes Project
Description: palliative care initiative in which clinicians elicits and implements small acts of kindness for dying patients and their families
Study: NCT05887115

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nurse Family Partnership
Description: During NFP visits, the nurse: 1) engages in a therapeutic nurse-client relationship focused on promoting client abilities and behavior change to protect and promote her own health and child's health; 2) provides service coordination based on client's identified needs, referring to available community services; 3) follows NFP Visit Guidelines tailoring them to the strengths and challenges of each family; 4) works with client to support a healthy pregnancy by recognizing and reducing risk factors and promoting prenatal health care, healthy diet, exercise, and stress management; and 5) gathers data on program implementation and maternal and child health. The visits include content from six domains: personal health, environmental health, life-course, maternal role, family and friends, and health and human services. Nurses use educational materials to address the content from the six domains with their clients.
Study: NCT04877730

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fully Closed Loop (FCL)
Description: Closed loop without a meal anticipation module without announced carbohydrate

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fully Closed Loop with meal anticipation module (FCL+)
Description: Closed loop with a meal anticipation module and without announced carbohydrate

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hybrid Closed Loop (HCL)
Description: Closed loop without a meal anticipation module with announced carbohydrate
Study: NCT05929209

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Assessment of disease biomarkers
Description: Assessment of serum, histological and radiological biomarkers
Study: NCT06349642

Intervention type: PROCEDURE
Intervention: Biospecimen Collection
Description: Undergo optional research blood sample.

Intervention type: PROCEDURE
Intervention: Tissue Collection
Description: Tissue specimen collection will be completed with your scheduled standard of care biopsy if possible. If standard of care biopsy is already completed or the research biopsy wasn\&#39;t collected at the time as your standard of care biopsy, then the research biopsy will be scheduled for a different day for research purposes only.
Study: NCT04802720

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Cancer Caregivers (CBT-C)
Description: The sessions are outlined as follow:~1. psychoeducation, goal-setting, and describing the rationale for CBT (Session 1);~2. coping effectiveness training (Session 2);~3. identifying unhelpful cognitions and dysfunctional beliefs (Session 3);~4. challenging and restructuring unhelpful cognitions (Session 4);~5. behavioral activation within the limitations of the caregiving context (Session 5);~6. problem-solving (Session 6);~7. communication strategies and assertiveness training (Session 7);~8. consolidating gains, maintenance, and relapse prevention (Session 8).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Emotion Regulation Therapy for Cancer Caregivers (ERT-C)
Description: The sessions are outlined as follow:~1. psychoeducation and motivation/dysregulation cue detection within caregiving contexts (Session 1);~2. attention regulation skills training (Sessions 1-2);~3. training in metacognitive skills (Sessions 3-4);~4. exposure to proactive living in the face of risk and loss while applying skills (Sessions 5-7);~5. consolidating gains, taking larger proactive steps, and relapse prevention (Session 8).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Emotion Regulation Therapy for Cancer Caregivers (ERT-C)
Description: The sessions are outlined as follow:~1. psychoeducation and motivation/dysregulation cue detection within caregiving contexts (Session 1);~2. attention regulation skills training (Sessions 1-2);~3. training in metacognitive skills (Sessions 3-4);~4. exposure to proactive living in the face of risk and loss while applying skills (Sessions 5-7);~5. consolidating gains, taking larger proactive steps, and relapse prevention (Session 8).
Study: NCT05565638

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prolonged Fasting Intervention
Description: promote a 14-hour fast during the nighttime hours

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: EDUCATION CONTROL
Description: introductory session with a health coach and educational information will be provided. Participants will also receive one email and one text message per week with tips on healthy living
Study: NCT00756691

Intervention type: OTHER
Intervention: 18F-FAZA
Description: Radioactive dose of 110-600 MBq per injection. A single pre-treatment injection of 18F-FAZA will be permitted per patient

Intervention type: OTHER
Intervention: 18F-FAZA
Description: Radioactive dose of 110-600 MBq per injection. A single pre-treatment injection of 18F-FAZA will be permitted per patient
Study: NCT06499493

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial induction in gastrocnemius muscle
Description: A 3-pass shallow leg gliding technique was applied first, followed by 5 minutes of the deep myofascial calf induction technique described by Pilat.
Study: NCT05167305

Intervention type: OTHER
Intervention: This is an observational study
Description: This is an observational study
Study: NCT06134219

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MF course
Description: A course consisting of six 2-hour-meetings every two-weeks with 10-15 participants (12 weeks in total). The meetings have different themes related to MF, such as understanding, practices for a deeper understanding of emotions, balance in everyday life with rest and activity, meditation practice to give time for brain rest, and mindfulness).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual health care
Description: The usual health care consists of one or few follow-up visits with blood tests at Sahlgrenska university hospital in Gothenburg or follow-up at the primary care after the end of treatment for Graves' treatment.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual health care
Description: The usual health care consists of one or few follow-up visits with blood tests at Sahlgrenska university hospital in Gothenburg or follow-up at the primary care after the end of treatment for Graves' treatment.
Study: NCT05077930

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Convalescent plasma
Description: The intervention group will receive 200 or 400 mL of high-titer COVID-19 convalescent plasma, ABO compatible with the patient, within 24 hours of randomization.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: The active comparator group will receive oxygen supplementation, corticoids, antiretrovirals, and/or monoclonal antibodies according to the institutional protocol.
Study: NCT04796597

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Subcutaneous implantation of Epios sub-scalp leads
Description: The sub-scalp Epios Leads will be implanted by a trained neurosurgeon and will provide epicranial EEG recording of specific cortical areas identified by the neurologist.
Study: NCT05899361

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electromagnetic Guided Laparoscopy
Description: Standard Care

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound
Description: Standard Care
Study: NCT06232876

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Blinded continuous vital sign monitoring
Description: Continuous blinded vital sign monitoring.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Unblinded continuous vital sign monitoring
Description: Continuous unblinded vital sign monitoring.
Study: NCT05414890

Intervention type: DIAGNOSTIC_TEST
Intervention: CBA-TSA
Description: Compare the specificity, sensitivity, and clinical correlation between CBA and CBA-TSA, in detecting AQP4, MOG, and NMDAR IgG
Study: NCT05466058

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: palpation - ultrasonography
Description: Physical therapist will assess patients to detect site of pathology (A1, A2, A3, A4, A5, midpalm or wrist) then patients will be refereed to radiologist who will detect site of pathology by sonography

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: palpation - ultrasonography
Description: Physical therapist will assess patients to detect site of pathology (A1, A2, A3, A4, A5, midpalm or wrist) then patients will be refereed to radiologist who will detect site of pathology by sonography
Study: NCT05827861

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HeartAge
Description: HeartAge is a phenotypic age-based risk presentation which is a modified tool for CVD risk communication based on the Framingham risk Score. The Heart-Age risk presentation is the age at which an individual of the same sex would be expected to experience the same absolute risk as the individual, had their risk factors been 'normal' based on the clinical guidelines.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HeartAge
Description: HeartAge is a phenotypic age-based risk presentation which is a modified tool for CVD risk communication based on the Framingham risk Score. The Heart-Age risk presentation is the age at which an individual of the same sex would be expected to experience the same absolute risk as the individual, had their risk factors been 'normal' based on the clinical guidelines.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HeartAge
Description: HeartAge is a phenotypic age-based risk presentation which is a modified tool for CVD risk communication based on the Framingham risk Score. The Heart-Age risk presentation is the age at which an individual of the same sex would be expected to experience the same absolute risk as the individual, had their risk factors been 'normal' based on the clinical guidelines.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HOPE-CVD Mobile App
Description: The HOPE-CVD mobile app is an evidence-based behaviour change platform that runs for 24 weeks. The programme supports behavioural modification through seven self-care behaviours (active living, exercise, weight management, blood pressure-friendly diet, cholesterol-friendly diet, medication adherence and smoke-free lifestyle). To adopt a digital delivery of Motivational Interviewing and Cognitive Behavioural Therapy, the HOPE-CVD platform incorporates interactive decision aids, dramatic vignettes, expert content, peer videos and behaviour tracking.
Study: NCT05675670

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AI-enabled ECG-based Screening Tool
Description: Primary care clinicians in the intervention group had access to the report, which displayed whether the AI-ECG result was positive or negative. The system will send a message to corresponding physicians if positive finding.
Study: NCT05827861

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HOPE-CVD Mobile App
Description: The HOPE-CVD mobile app is an evidence-based behaviour change platform that runs for 24 weeks. The programme supports behavioural modification through seven self-care behaviours (active living, exercise, weight management, blood pressure-friendly diet, cholesterol-friendly diet, medication adherence and smoke-free lifestyle). To adopt a digital delivery of Motivational Interviewing and Cognitive Behavioural Therapy, the HOPE-CVD platform incorporates interactive decision aids, dramatic vignettes, expert content, peer videos and behaviour tracking.
Study: NCT05982990

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
Description: 2 inhalations in one study period
Study: NCT05827861

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Genetic Risk Score
Description: Participants will undergo genetic testing from which a genetic risk score for CVD will be estimated. they will receive a genetic risk communication which indicates which quartile of genetic risk they are at in comparison to the rest of the population. The report also contains information on what this risk means for their chances of developing cardiovascular disease in the future.
Study: NCT04701892

Intervention type: OTHER
Intervention: Indicators of central sensitisation
Description: Indicators of central sensitisation, assessed by the Central Sensitization Inventory
Study: NCT05281159

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Risk Information
Description: This group will receive an SMS text message highlighting their risk for CRC on top of the content in the Control arm.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Risk Information + Action
Description: This group will receive an SMS text message highlighting their risk for CRC and the importance of taking quick action, on top of the content in the Control arm.
Study: NCT06606210

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: InnovaMatrix® AC
Description: Weekly dressing applications